Navigation Links
MU researcher's photoacoustic device finds cancer cells before they become tumors
Date:1/5/2012

COLUMBIA, Mo. Early detection of melanoma, the most aggressive skin cancer, is critical because melanoma will spread rapidly throughout the body. Now, University of Missouri researchers are one step closer to melanoma cancer detection at the cellular level, long before tumors have a chance to form. Commercial production of a device that measures melanoma using photoacoustics, or laser-induced ultrasound, will soon be available to scientists and academia for cancer studies. The commercial device also will be tested in clinical trials to provide the data required to obtain U.S. Food and Drug Administration approval for early diagnosis of metastatic melanoma and other cancers.

"Using a small blood sample, our device and method will provide an earlier diagnosis for aggressive melanoma cancers," said John Viator, associate professor of biomedical engineering and dermatology in the Christopher S. Bond Life Sciences Center. "We compare the detection method to watching an eight-lane highway full of white compact cars. In our tests, the cancer cells look like a black 18-wheeler."

Currently, physicians use CT or MRI scans for melanoma cancer detection, costing thousands of dollars. Viator's photoacoustic device emits laser light into a blood sample, and melanin within the cancer cells absorbs the light. Those cancer cells then expand as the lasers rapidly heat and then cool the cancer cells, making them prominent to researchers. The device also would capture the expanded cells, identifying the form of cancer the physicians are fighting and the best treatment method.

Viator has recently signed a commercialization license to begin offering the device and method to scientists and academia for research. They are also preparing studies for FDA approval for clinical use, which is expected to take approximately two to three years. Viator says the final device will look similar to a desktop printer, and the costs to run the tests in a hospital would be a few hundred dollars.

"We are attempting to provide a faster and cheaper screening method, which is ultimately better for the patient and the physician," Viator said. "There are several melanoma drugs on the horizon. Combined with the new photoacoustic detection method, physicians will be able to use targeted therapies and personalized treatments, changing the medical management of this aggressive cancer. Plus, if the test is as accurate as we believe it will be, our device could be used as a standard screening in targeted populations."


'/>"/>
Contact: Steven Adams
AdamsST@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert  

Related biology news :

1. Frogs use calls to find mates with matching chromosomes, University of Missouri researchers find
2. Viagra against heart failure: Researchers at the RUB and from Rochester throw light on the mechanism
3. DOE researchers achieve important genetic breakthroughs to help develop cheaper biofuels
4. Drugs used to overcome cancer may also combat antibiotic resistance: McMaster researchers
5. Researchers develop new method of cleaning toxins from the oilsands
6. Researchers discover a way to significantly reduce the production costs of fuel cells
7. San Diego Zoo researchers contribute to project using mummy DNA to differentiate croc species
8. Researchers create living neon signs composed of millions of glowing bacteria
9. Georgetown researchers lead discovery expected to significantly change biomedical research
10. 4 UC Riverside researchers receive national recognition
11. Researchers assess effects of a world awash in nitrogen
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MU researcher's photoacoustic device finds cancer cells before they become tumors
(Date:10/13/2018)... (PRWEB) , ... October 12, 2018 , ... ... announced it will host a booth at premier packaging event PACK EXPO International ... the Packaging Machinery Manufacturers Institute (PMMI), of which HOLLOWAY AMERICA is a member. ...
(Date:10/11/2018)... ... October 09, 2018 , ... ... counsels, and supports high-growth, high-impact life science and biotechnology companies, announced today ... nonprofit disease foundations to discuss their investment philosophies, explain their fund and ...
(Date:10/11/2018)... ... October 10, 2018 , ... For the first ... patients to learn about their treatment options. The unique patient education tool seeks ... cancer (TNBC), and was developed through a collaboration between the Centers for ...
Breaking Biology News(10 mins):
(Date:10/5/2018)... (PRWEB) , ... October 04, 2018 , ... ... that it has received a Spine Technology Award from Orthopedics This Week during ... last week. The Power T Handle is a surgical instrument that delivers operating ...
(Date:10/2/2018)... ... October 02, 2018 , ... ... solutions for biopharmaceutical R&D, today announced a new out-of-the-box integration of the ... a leading international pharmaceutical and laboratory equipment supplier. This enables the automatic ...
(Date:9/28/2018)... ... September 28, 2018 , ... GlycoMark®, Inc. has announced ... the GlycoMark test, the only FDA-cleared blood test specific to detecting recent hyperglycemia ... and offer the GlycoMark test to its network of physicians through its sales ...
(Date:9/27/2018)... ... September 26, 2018 , ... ... debuted its focus® Pedicle Screw System today at the North American Spine Society ... , The Nvision focus Pedicle Screw System, which received clearance from the ...
Breaking Biology Technology: